There are currently 472 clinical trials in Kansas City, Kansas looking for participants to engage in research studies. Trials are conducted at various facilities, including University of Kansas Medical Center, University of Kansas Cancer Center, Kansas University Medical Center and Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study
NCT03545607
Recruiting
A Phase 3 study to examine the safety and effectiveness of the allogeneic, adult stem cell investigational product, MultiStem, in adults who have suffered an acute ischemic stroke in the previous 18-36 hours.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/08/2022
Locations: Athersys Investigational Site 119, Kansas City, Kansas
Conditions: Ischemic Stroke
Register for Updates
Improving Pain Management Via Spinal Cord Stimulation and Blood Pressure Reduction
NCT04676399
Recruiting
The purpose of this study (PASSION study) is to monitor symptoms of chronic pain before and after 2 weeks of a standard drug commonly used to treat elevated blood pressure compared with 2 weeks of placebo (crossover design) so that we may better understand how blood pressure affects your level of pain. This study is not testing an experimental drug.
Gender:
All
Ages:
Between 40 years and 79 years
Trial Updated:
02/08/2022
Locations: The Marc A. Asher Comprehensive Spine Center at the Kansas University Medical Center, Kansas City, Kansas
Conditions: Chronic Pain, Hypertension, Diuretics Drug Reactions, SCS
Register for Updates
Feasibility of Home-based Exercise Program for Adults With Cystic Fibrosis
NCT05239611
Recruiting
The main objective of this clinical pilot study is to evaluate the feasibility and impact of a home-based exercise program on clinical and patient-centered outcomes in adult with cystic fibrosis (CF) and inform the design of a larger clinical trial.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/03/2022
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Cystic Fibrosis
Register for Updates
Pharmacogenomic Modulators of Impaired Exercise Adaptation in Statin Users
NCT04636138
Recruiting
HMG-CoA reductase inhibitors (statins) have beneficial effects (prevent stroke, heart attack) but also some bad ones (block some good effects of exercise). Individuals have genetic variations in proteins that metabolize/transport statins. The investigators hypothesize that these variations modulate the relationship between statin use and lack of benefit from exercise. The investigators will test this by having statin-users do supervised exercise for 6 weeks, measuring the cardiorespiratory fitne... Read More
Gender:
All
Ages:
Between 35 years and 65 years
Trial Updated:
11/16/2021
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: HMG-CoA Reductase Inhibitor Toxicity
Register for Updates
Natural History of COVID-19-Related Atrial Fibrillation
NCT04830774
Recruiting
The unCOVer-AF prospective, multicenter registry aims at determining the natural history of atrial fibrillation (AF) via continuous cardiac rhythm monitoring in patients with a first arrhythmic episode during COVID-19 hospitalization.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/15/2021
Locations: Kansas City Heart Rhythm Institute, Overland Park, Kansas City, Kansas
Conditions: COVID-19, Atrial Fibrillation New Onset
Register for Updates
LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors
NCT04979156
Recruiting
Conventional monopolar or bipolar transurethral resection of bladder tumors is the most common method for resection of a bladder mass. En bloc resection has demonstrated success in the literature utilizing different techniques and lasers, including utilizing the Ho:YAG and Tm:YAG lasers. A recent metanalysis revealed several benefits to laser en bloc resection including less complications and lower recurrence rate.22 Subsequently, laser technology has also advanced with the development of a supe... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
11/04/2021
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Bladder Cancer, Surgery
Register for Updates
Post COVID-19 Biorepository
NCT04885504
Recruiting
Establish a biorepository, clinical data registry, and radiographic image database from individuals who were COVID positive at one time and are being seen for outpatient follow-up or a separate study visit.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/28/2021
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Coronavirus Infection
Register for Updates
Function of Circulating Exosomes in Sepsis-induced Immunosuppression
NCT04979767
Recruiting
This is a single-center prospective bio-specimen analysis and observational study aiming to define immune pathways disrupted in bacterial sepsis and to identify clinically useful biomarkers of immune status.
Gender:
All
Ages:
50 years and above
Trial Updated:
07/16/2021
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Sepsis, Septic Shock, Sepsis Syndrome, Sepsis Bacterial, Sepsis, Severe, Sepsis Bacteremia
Register for Updates
Pulmonary Hypertension Biorepository and Registry
NCT04808596
Recruiting
Establish a pulmonary hypertension registry and biorepository to lead towards a further understanding of the disease.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/27/2021
Locations: The University of Kansas Medical Center, Kansas City, Kansas +1 locations
Conditions: Pulmonary Hypertension, Pulmonary Arterial Hypertension, Pulmonary Hypertension Due to Left Heart Disease, Pulmonary Hypertension, Primary, Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Pulmonary Hypertension, Primary, 4, Pulmonary Hypertension, Primary, 2, Pulmonary Hypertension, Primary, 3, Chronic Thromboembolic Pulmonary Hypertension
Register for Updates
Early PKD Observational Cohort Study
NCT02936791
Recruiting
This observational study will collect blood and urine and clinical information from individuals with early-stages of polycystic kidney disease (PKD), their unaffected siblings and normal volunteers to create a biobank, also called a biorepository. The long-term goal is to develop new knowledge on biological markers or biomarkers that indicate changes in the disease progression. An understanding of biomarkers for early renal cyst growth will benefit PKD patients as new therapies are being develop... Read More
Gender:
All
Ages:
Between 4 years and 35 years
Trial Updated:
05/06/2021
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Polycystic Kidney Disease
Register for Updates
Evaluation of Multi-Tined Expandable Electrode (MEE) Efficacy and Safety in Treatment of Lumbar Facet Arthropathy by Radiofrequency Neurotomies Compared to Conservative Medical Management.
NCT04730700
Recruiting
The purpose of this study is to better understand how people feel after a radiofrequency ablation standard of care surgery using a different type of needle (multi-tined expandable electrode/MEE) in comparison to receiving conventional medical management (CMM) techniques.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/06/2021
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Chronic Low-back Pain
Register for Updates
Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML
NCT03250338
Recruiting
This is a randomized, multi-center, double-blind, placebo-controlled study designed to evaluate the efficacy of crenolanib administered following salvage chemotherapy, consolidation chemotherapy, post bone marrow transplantation and as maintenance in relapsed/refractory AML subjects with FLT3 activating mutation.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
04/28/2021
Locations: Kansas University, Kansas City, Kansas
Conditions: Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations
Register for Updates